John Markels insider trades
Open-market stock purchases and sales by John Markels, Director at Vaxcyte, Inc, from SEC Form 4 filings since Feb 11, 2020.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -95%.
Open-market stock purchases and sales by John Markels, Director at Vaxcyte, Inc, from SEC Form 4 filings since Feb 11, 2020.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -95%.